First half of 2022: Boehringer Ingelheim continues growth pa

Growing late-stage research pipeline, addressing areas of high unmet medical need Pipeline includes areas such as rare skin disease, pulmonary fibrosis, oncology and central nervous system

Related Keywords

Michael Schmelmer , Group Functions , Animal Health , Boehringer Ingelheim , Research Development , Human Pharma , Managing Directors , Finance Group , African Swine Fever , Ten Wolde , Global Media Relations , First , Calf , 022 , Boehringer , Ingelheim , Ontinues , Growth , Race , Trengthens , Research , Pipeline ,